Daiwa Securities Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Daiwa Securities Group's NVAX Position: Q1 2026 in Review
Daiwa Securities Group sold out of Novavax (NVAX) in Q1 2026, closing a stake of 492 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in NVAX in Q1 2018 and held it in 27 quarters. The position peaked at $1.13M in Q2 2021. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Daiwa Securities Group reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 492 Novavax shares in Q1 2026, an estimated $3K.
- Daiwa Securities Group first reported a position in Novavax in Q1 2018 and held it in 27 quarters.
- Daiwa Securities Group's Novavax position peaked at $1.13M in Q2 2021.
- 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.